FDA Inspection 1180699 — Community Blood Center Of Greater Kansas City

Community Blood Center Of Greater Kansas City — FEI 1972933

The FDA completed an inspection of Community Blood Center Of Greater Kansas City on September 27, 2022 in Kansas City, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 27, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Kansas City, MO (United States)